Endocrinology

The Phase 2 CARDINAL study is evaluating bardoxolone methyl (bardoxolone) in patients with chronic kidney disease because of Alport syndrome.

While conventional methods require some type of skin prick, scientists from the University of Bath have proven the concept of needleless CGM.

André the Giant, examines the life and work history of the WWE Hall of Famer. Unbeknownst to many, his size was the result of gigantism, a disease caused by excess growth hormone. The condition led to his eventual diagnosis with acromegaly, a rare endocrine disorder.

Women with PCOS face increased risk of psychiatric morbidity and their children are more likely to be diagnosed with ADHD or autism.

When taken early in a pregnancy, mifepristone can end a pregnancy that is less than 49 days along. Another notable trait of the drug, though, is its ability to control the high blood sugar in patients with Cushing syndrome who have type 2 diabetes and have either failed surgery or are not candidates for it.

New data has elucidated a mechanism of action by which hormonal replacement therapy could help prevent T2D in women after menopause.

Researchers note that efforts are needed to align clinical practice with clinical guidelines.

Study results showed significant HbA1c reduction when Bydureon was added to insulin glargine therapy versus insulin glargine alone.

The Beyond Type 1 Science Advisory Council member explains the warning signs of diabetes.

Doctors of osteopathic medicine have long sought to be viewed equally in the eyes of their colleagues, but their differences may have helped shape modern medicine. Does stigma still exist?

The device is the first of its class and will be designated as a class II device, subjecting it to special controls that will serve as criteria for future devices.

The Max SoloStar from Sanofi is capable of carrying 300 units/mL of insulin glargine, and administer 160 units/mL in a single injection.

This week on MDNN: America trends toward healthier outcomes, the first-ever gene therapy procedure was performed, and President Donald Trump declared his stance on opioid traffickers.

Integrating transgender-specific content into medical curricula improves student knowledge and comfort with transgender medical care.

The survey estimates from the National Center for Health Statistics report that more people are vaccinating for flu and testing for HIV.

Pregnant women with polycystic ovary syndrome taking metformin were 5% less likely to experience a miscarriage or preterm birth compared to those on placebo.

The GLP-1 receptor agonist is a similar, longer-acting formula to that of liraglutide, another successful therapy from Novo Nordisk that was recently approved for its second indication of lowering cardiovascular risk.

Adults with obesity treated with semaglutide 0.4 mg lost up to 13.8% of body weight after 52 weeks, significantly more weight than those treated with placebo who lost 2.3%.

The device will offer real-time tracking and alerts for glucose level high and low events, as well as telemedicine capabilities.

A joint statement from the Endocrine Society, the ADA, the AACE, and the AADE expressed strong disagreement with the ACP’s new guidelines, which raised goal A1C levels to between 7% and 8% for patients with T2D.

The therapies come on the tail of Amgen's failed attempt to receive a 6-month exclusivity extension for Sensipar.

The updated guidelines state that patients should be treated to achieve A1C levels between 7% and 8%.

A new classification of diabetes may provide information about underlying disease mechanisms and ultimately guide the choice of therapy.

Carb counting, bar-code recognition, log-book, exercise tracker, insulin calculator -- and more, all in each one of these 5 apps.